No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
www.magnasense.comNo one on the platform currently holds AEGIR.ST.
No tracked institution reports a position in AEGIR.ST as of their last filing.
No one on the platform has traded AEGIR.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| AEGIR.STAegirBio AB (publ) | $0.43 | +3.88% | $15M | — |
| AMNI.STAmniotics AB (publ) | $0.01 | +5.88% | $15M | — |
| BIOS.STBioservo Technologies AB (publ) | $0.02 | -5.88% | $1M | — |
| CYXO.STCyxone AB (publ) | $0.02 | +0.00% | $7M | — |
| DIABIO.STDiagonal Bio AB (publ) | $0.01 | +0.00% | $20M | — |
| IDOGEN.STIdogen AB (publ) | $0.12 | -2.82% | $13M | — |
| L2S.STLearning 2 Sleep L2S AB (publ) | $0.02 | +2.50% | $12M | — |
Source: Financial Modeling Prep · peers by sector/industry